DE69317418T2 - PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN - Google Patents

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN

Info

Publication number
DE69317418T2
DE69317418T2 DE69317418T DE69317418T DE69317418T2 DE 69317418 T2 DE69317418 T2 DE 69317418T2 DE 69317418 T DE69317418 T DE 69317418T DE 69317418 T DE69317418 T DE 69317418T DE 69317418 T2 DE69317418 T2 DE 69317418T2
Authority
DE
Germany
Prior art keywords
pct
agonistic
pharmaceutical compositions
sec
rectal administrations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69317418T
Other languages
English (en)
Other versions
DE69317418D1 (de
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoire Glaxo Wellcome SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Glaxo Wellcome SA filed Critical Laboratoire Glaxo Wellcome SA
Publication of DE69317418D1 publication Critical patent/DE69317418D1/de
Application granted granted Critical
Publication of DE69317418T2 publication Critical patent/DE69317418T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69317418T 1992-05-07 1993-05-03 PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN Expired - Lifetime DE69317418T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (2)

Publication Number Publication Date
DE69317418D1 DE69317418D1 (de) 1998-04-16
DE69317418T2 true DE69317418T2 (de) 1998-07-30

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69317418T Expired - Lifetime DE69317418T2 (de) 1992-05-07 1993-05-03 PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN

Country Status (33)

Country Link
US (1) US5705506A (de)
EP (1) EP0639072B1 (de)
JP (1) JPH07506570A (de)
KR (1) KR100253111B1 (de)
AT (1) ATE163850T1 (de)
AU (1) AU670083B2 (de)
BE (1) BE1007024A5 (de)
BG (1) BG62120B1 (de)
BR (1) BR1100108A (de)
CA (1) CA2135179C (de)
CH (1) CH685920A5 (de)
CY (1) CY2039B1 (de)
CZ (1) CZ283512B6 (de)
DE (1) DE69317418T2 (de)
ES (1) ES2113533T3 (de)
FR (1) FR2690847B1 (de)
GB (2) GB9209882D0 (de)
GR (1) GR3026584T3 (de)
HK (1) HK95697A (de)
HU (2) HU227338B1 (de)
IE (1) IE75203B1 (de)
IL (1) IL105468A (de)
IT (1) IT1261471B (de)
NO (1) NO306700B1 (de)
NZ (1) NZ252132A (de)
OA (1) OA10109A (de)
RO (1) RO112993B1 (de)
RU (1) RU2118527C1 (de)
SG (1) SG46649A1 (de)
TW (1) TW231970B (de)
UA (1) UA37206C2 (de)
WO (1) WO1993021916A1 (de)
ZA (1) ZA933178B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ES2367294T3 (es) * 1998-03-26 2011-11-02 Astellas Pharma Inc. Preparación de liberación sostenida de un compuesto macrólido como tacrolimus.
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
KR101825972B1 (ko) 2010-10-15 2018-02-06 콘테라 파르마 에이피에스 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합
US10561618B2 (en) 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171450B (it) * 1980-08-12 1987-06-10 Glaxo Group Ltd Composti eterociclici indolici, procedimento per produrli e composizioni farmaceutiche che li contengono
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (de) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2574077A1 (fr) * 1984-12-04 1986-06-06 Glaxo Group Ltd Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
PT88255B (pt) * 1987-08-13 1995-03-01 Glaxo Group Ltd Processo para a preparacao de derivados do indole
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
US5705506A (en) 1998-01-06
BG62120B1 (bg) 1999-03-31
BE1007024A5 (fr) 1995-02-21
NZ252132A (en) 1996-09-25
IE75203B1 (en) 1997-08-27
NO306700B1 (no) 1999-12-13
GB2266665A (en) 1993-11-10
FR2690847B1 (fr) 1995-06-09
RO112993B1 (ro) 1998-03-30
ITRM930286A1 (it) 1994-11-06
IT1261471B (it) 1996-05-23
CZ283512B6 (cs) 1998-04-15
NO944214L (no) 1994-11-07
DE69317418D1 (de) 1998-04-16
CY2039B1 (en) 1998-04-30
HUT71418A (en) 1995-11-28
AU670083B2 (en) 1996-07-04
OA10109A (en) 1996-12-18
HU227338B1 (en) 2011-04-28
CA2135179A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
EP0639072A1 (de) 1995-02-22
SG46649A1 (en) 1998-02-20
FR2690847A1 (fr) 1993-11-12
HU211638A9 (en) 1995-12-28
TW231970B (de) 1994-10-11
GB9209882D0 (en) 1992-06-24
GR3026584T3 (en) 1998-07-31
RU2118527C1 (ru) 1998-09-10
JPH07506570A (ja) 1995-07-20
EP0639072B1 (de) 1998-03-11
BR1100108A (pt) 1999-12-07
ATE163850T1 (de) 1998-03-15
IE930339A1 (en) 1993-11-17
CA2135179C (en) 2000-12-05
ITRM930286A0 (it) 1993-05-06
WO1993021916A1 (en) 1993-11-11
ES2113533T3 (es) 1998-05-01
CH685920A5 (fr) 1995-11-15
IL105468A0 (en) 1993-08-18
CZ272394A3 (en) 1995-10-18
NO944214D0 (no) 1994-11-04
UA37206C2 (uk) 2001-05-15
ZA933178B (en) 1994-01-10
GB2266665B (en) 1996-05-22
HK95697A (en) 1997-08-08
AU4064093A (en) 1993-11-29
KR100253111B1 (en) 2000-07-01
IL105468A (en) 1998-09-24
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
HUP0100266A2 (hu) NMDA-receptor-antagonista hatású 1-aminoalkilciklohexánszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és előállításaik
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
DE69705300T2 (de) Cyclopropylalkansäurederivate
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
DE69317418T2 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN
ATE148989T1 (de) Partielle agonisten der strychnin unempfindlichen glycinmodulierenden stelle des n-methyl-d- aspartat-rezeptor-komplexes als neuropsycho- pharmakologische wirkstoffe
NO972623L (no) Farmasöytisk blanding omfattende lamotrigin
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
SE9702002D0 (sv) Novel compounds
HUP0002929A2 (hu) Tachikinin receptor antagonista hatású 2-acilamino-propán-aminok és az ezeket tartalmazó gyógyszerkészítmények
ATE216695T1 (de) VON INDOL ABGELEITETE AROMATISCHE ETHER ALS ß5HT1-LIKEß LIGANDEN
FI950209A (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
DE59303446D1 (de) Neue bis-phenyl-hexene
KR860000870A (ko) 신규 항고혈압제 및 항앙기나제와 그 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition